Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Current Assets: 2022-2025

Historic Current Assets for Day One Biopharmaceuticals (DAWN) over the last 3 years, with Sep 2025 value amounting to $490.0 million.

  • Day One Biopharmaceuticals' Current Assets fell 15.67% to $490.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $490.0 million, marking a year-over-year decrease of 15.67%. This contributed to the annual value of $562.3 million for FY2024, which is 49.85% up from last year.
  • Day One Biopharmaceuticals' Current Assets amounted to $490.0 million in Q3 2025, which was down 0.90% from $494.4 million recorded in Q2 2025.
  • In the past 5 years, Day One Biopharmaceuticals' Current Assets ranged from a high of $581.0 million in Q3 2024 and a low of $326.0 million during Q1 2024.
  • Over the past 3 years, Day One Biopharmaceuticals' median Current Assets value was $469.9 million (recorded in 2023), while the average stood at $458.4 million.
  • Data for Day One Biopharmaceuticals' Current Assets shows a peak YoY increase of 56.01% (in 2025) and a maximum YoY decrease of 15.67% (in 2025) over the last 5 years.
  • Quarterly analysis of 4 years shows Day One Biopharmaceuticals' Current Assets stood at $347.9 million in 2022, then rose by 7.88% to $375.3 million in 2023, then spiked by 49.85% to $562.3 million in 2024, then fell by 15.67% to $490.0 million in 2025.
  • Its Current Assets was $490.0 million in Q3 2025, compared to $494.4 million in Q2 2025 and $508.7 million in Q1 2025.